⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22581405 | 0.88 | MLYCD (0.31) | — | |
| SCHEMBL31623897 | 0.83 | MLYCD (0.32) | — | |
| SCHEMBL24124347 | 0.80 | MLYCD (0.32) | — | |
| SCHEMBL31623216 | 0.76 | — | — | |
| SCHEMBL31623852 | 0.76 | LMNA (0.33) | — | |
| SCHEMBL31624035 | 0.76 | — | — | |
| SCHEMBL17048856 | 0.74 | SMN1; SMN2 (0.34) | — | |
| SCHEMBL28617921 | 0.72 | — | — | |
| SCHEMBL22581463 | 0.70 | — | — | |
| SCHEMBL29137733 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128873-A1 | HETEROCYCLIC PYRIDINONE COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE | VIGIL NEUROSCIENCE, INC. (US) | 2025-06-19 | — | — | WO | disclosed |